13F filerCIK 1536411 ↗
Duquesne Family Office
You are looking at Q1 2025. See the latest, Q3 2026 →
Reported value
$3.06B
−18% on the quarter before
Positions
52
12 new, 38 sold out
Top 10
59.8%
of the value
Est. gain
−$152.6M
on stocks held all quarter
Est. return
−6.5%
on those stocks since Q4 2024
Positions as of Mar 31, 2025, from Duquesne Family Office's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2024. Striped tiles are options.
Largest buys
Since Q4 2024, sized at quarter-end prices.
- Teva Pharmaceutical Inds Ltd~$90.4MAdded, 5.3% → 7.5% of the portfolio+5,882,350 shares
- DocuSign~$87.5MNew, 0.0% → 2.9% of the portfolio+1,074,655 shares
- TSMC~$81.5MAdded, 0.6% → 3.2% of the portfolio+491,265 shares
- Flutter Entmt Plc~$79.6MAdded, 0.1% → 2.7% of the portfolio+359,375 shares
- Insmed Inc~$59.2MAdded, 1.1% → 3.4% of the portfolio+775,580 shares
- Ccc Intelligent Solutions Hl~$50.5MNew, 0.0% → 1.7% of the portfolio+5,595,039 shares
- Eqt Corp~$45.9MNew, 0.0% → 1.5% of the portfolio+859,345 shares
- Caesars Entertainment Inc Ne~$38.7MNew, 0.0% → 1.3% of the portfolio+1,548,420 shares
- Twilio~$35.5MNew, 0.0% → 1.2% of the portfolio+362,155 shares
- Capital One Finl Corp~$35.4MNew, 0.0% → 1.2% of the portfolio+197,670 shares
Largest sells
Since Q4 2024, sized at quarter-end prices.
- Seagate Technology Hldngs Pl~$114.2MCut, 3.6% → 0.6% of the portfolio−1,344,599 shares
- Skechers U S A Inc~$72.3MSold out, 1.9% → 0.0% of the portfolio−1,074,840 shares
- Slm Corp~$69.5MSold out, 1.9% → 0.0% of the portfolio−2,520,275 shares
- United States Stl Corp~$54.7MSold out, 1.5% → 0.0% of the portfolio−1,610,040 shares
- Warner Bros Discovery Inc~$49.2MSold out, 1.3% → 0.0% of the portfolio−4,657,650 shares
- United Airls Hldgs Inc~$46.6MCut, 2.7% → 0.8% of the portfolio−675,120 shares
- American AirlCALL~$44.9MSold out, 1.2% → 0.0% of the portfolio−2,573,500 underlying
- Philip Morris Intl Inc~$39.2MCut, 4.4% → 5.7% of the portfolio−246,987 shares
- Vistra~$39.1MSold out, 1.0% → 0.0% of the portfolio−283,355 shares
- Coherent Corp~$38.9MCut, 7.2% → 4.7% of the portfolio−598,860 shares
Holdings
As of Mar 31, 2025; changes in shares since Dec 31, 2024.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Natera IncCOM · shares −4.6% · price −10.7% | 15.7% | $481.1M | −$57.5M | ||||||
| Teva Pharmaceutical Inds LtdSPONSORED ADS · shares +65% · price −30.3% | 7.5% | $228.7M | −$60.0M | ||||||
| Coupang IncCL A · shares +4.5% · price −0.2% | 6.7% | $204.0M | −$444,681 | ||||||
| Woodward IncCOM · shares −10% · price +9.7% | 6.5% | $200.3M | +$17.6M | ||||||
| Philip Morris Intl IncCOM · shares −18% · price +31.9% | 5.7% | $175.4M | +$42.4M | ||||||
| Coherent CorpCOM · shares −21% · price −31.4% | 4.7% | $144.3M | −$66.2M | ||||||
| MercadoLibreCOM · shares 0% · price +14.7% | 3.4% | $104.8M | +$13.5M | ||||||
| Insmed IncCOM PAR $.01 · shares +131% · price +10.5% | 3.4% | $104.4M | +$4.3M | ||||||
| TSMCSPONSORED ADS · shares +457% · price −15.9% | 3.2% | $99.4M | −$3.4M | ||||||
| DocuSignCOM · shares New | 2.9% | $87.5M | — | ||||||
| Flutter Entmt PlcSHS · shares +1,985% · price −14.3% | 2.7% | $83.6M | −$670,994 | ||||||
| Eli LillyCOM · shares +52% · price +7.0% | 2.6% | $78.3M | +$3.4M | ||||||
| Ypf Sociedad AnonimaSPON ADR CL D · shares +23% · price −17.6% | 2.4% | $72.7M | −$12.6M | ||||||
| Verona Pharma PlcSPONSORED ADS · shares +13% · price +36.7% | 2.1% | $63.6M | +$15.1M | ||||||
| Barclays PlcADR · shares +20% · price +15.6% | 1.9% | $58.6M | +$6.6M | ||||||
| WabtecCOM · shares +7.5% · price −4.3% | 1.8% | $54.6M | −$2.3M | ||||||
| Ccc Intelligent Solutions HlCOM · shares New | 1.7% | $50.5M | — | ||||||
| Kinder MorganCOM · shares −26% · price +4.1% | 1.5% | $47.2M | +$1.9M | ||||||
| Eqt CorpCOM · shares New | 1.5% | $45.9M | — | ||||||
| Delta Air Lines Inc DelCALLCOM NEW · shares 0% | 1.4% | $41.4M | — | ||||||
| Caesars Entertainment Inc NeCOM · shares New | 1.3% | $38.7M | — | ||||||
| Freeport-McMoRanCL B · shares +34% · price −0.6% | 1.3% | $38.5M | −$167,196 | ||||||
| Daktronics IncCOM · shares +17% · price −27.8% | 1.2% | $37.4M | −$12.3M | ||||||
| Global X FdsGB MSCI AR ETF · shares −19% · price −2.3% | 1.2% | $35.8M | −$842,707 | ||||||
| TwilioCL A · shares New | 1.2% | $35.5M | — | ||||||
| Total 52 positions | 100% | $3.06B | −$152.6M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2024 to Q1 2025: 37 stocks held throughout, down $152.6M (−6.5%).
- Philip Morris Intl Inc+$42.4M+32%
- Woodward Inc+$17.6M+10%
- Verona Pharma Plc+$15.1M+37%
- MercadoLibre+$13.5M+15%
- Barclays Plc+$6.6M+16%
- Daktronics Inc−$12.3M−28%
- Ypf Sociedad Anonima−$12.6M−18%
- Natera Inc−$57.5M−11%
- Teva Pharmaceutical Inds Ltd−$60.0M−30%
- Coherent Corp−$66.2M−31%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 16, 2026 | $4.47B−14% | SEC ↗ |
| Q2 2026 | Aug 14, 2026 | $5.21B+54% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $3.38B−25% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $4.49B+11% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $4.06B−0% | SEC ↗ |
| Q2 2025 | Aug 15, 2025 | $4.07B+33% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $3.06B−18% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $3.72B+26% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $2.95B+1% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $2.92B−34% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $4.39B+31% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $3.35B+20% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $2.79B−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $2.87B+25% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $2.31B+14% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $2.02B+15% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $1.76B+28% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $1.38B−40% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $2.31B−16% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $2.76B−10% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $3.08B−24% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 (amended) | $4.04B−11% | SEC ↗ |
| Q1 2021 | May 17, 2021 (amended) | $4.53B+22% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $3.71B+8% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $3.44B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $3.27B+32% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $2.47B−28% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $3.41B+33% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $2.57B−24% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $3.37B−2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $3.45B+100% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $1.73B−18% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $2.10B+2% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $2.07B+14% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $1.81B−9% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $1.98B−10% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $2.20B+18% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $1.87B+22% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $1.52B+49% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $1.03B−9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $1.13B+30% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $870.7M−35% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $1.34B | SEC ↗ |